Delisting risk
IN8bio
Develops gamma-delta T-cell therapies and engagers for cancer and autoimmune disease.
$1.04
After-hours close+0.01 (+0.82%)
At close$1.04(−0.48%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.31 | — | — |
| Aug 2026 | −$0.34 | −$0.25 | +27.3% |
| May 2026 | −$0.59 | −$0.26 | +55.9% |
| Mar 2026 | −$0.18 | −$0.26 | −44.4% |
| Nov 2025 | −$1.20 | −$0.85 | +29.2% |
The latest year is open to everyone — the 28 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Sep 2021 | |||
| Jul 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$0.31 | — | — | — | — | — |
| Aug 6, 2026 | −$0.34 | −$0.25 | +27.3% | — | — | — |
| May 7, 2026 | −$0.59 | −$0.26 | +55.9% | — | — | — |
| Mar 12, 2026 | −$0.18 | −$0.26 | −44.4% | $16.0M | — | — |
| Nov 6, 2025 | −$1.20 | −$0.85 | +29.2% | — | — | — |
The latest year is open to everyone — the 28 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 7, 2025 | ||||||
| Mar 13, 2025 | ||||||
| Nov 12, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 9, 2024 | ||||||
| Mar 14, 2024 | ||||||
| Nov 9, 2023 | ||||||
| Aug 10, 2023 | ||||||
| May 12, 2023 | ||||||
| Mar 30, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Aug 12, 2022 | ||||||
| May 12, 2022 | ||||||
| Mar 17, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Sep 10, 2021 | ||||||
| Jul 30, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Sep 30, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Sep 30, 2019 | ||||||
| Jun 30, 2019 | ||||||
| Mar 31, 2019 | ||||||
| Jun 30, 2018 | ||||||
| Mar 31, 2018 | ||||||